Macquarie Group LTD Amicus Therapeutics, Inc. Transaction History

Macquarie Group LTD

  • $85.1 Billion
  • Q2 2024

A detailed history of Macquarie Group LTD transactions in Amicus Therapeutics, Inc. stock. As of the latest transaction made, Macquarie Group LTD holds 7,121,222 shares of FOLD stock, worth $76.3 Million. This represents 0.08% of its overall portfolio holdings.

Number of Shares
7,121,222
Previous 7,070,733 0.71%
Holding current value
$76.3 Million
Previous $83.3 Million 15.19%
% of portfolio
0.08%
Previous 0.1%

Shares

19 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 09, 2024
BUY
$9.04 - $11.75 $456,420 - $593,245
50,489 Added 0.71%
7,121,222 $70.6 Million
Q1 2024

May 14, 2024
SELL
$11.43 - $14.24 $1.65 Million - $2.05 Million
-144,277 Reduced 2.0%
7,070,733 $83.3 Million
Q4 2023

Feb 14, 2024
BUY
$9.97 - $14.52 $23,509 - $34,238
2,358 Added 0.03%
7,215,010 $102 Million
Q3 2023

Nov 14, 2023
BUY
$11.78 - $13.86 $3.42 Million - $4.03 Million
290,671 Added 4.2%
7,212,652 $87.7 Million
Q2 2023

Aug 14, 2023
SELL
$10.72 - $13.3 $2.67 Million - $3.31 Million
-249,054 Reduced 3.47%
6,921,981 $86.9 Million
Q1 2023

May 15, 2023
BUY
$10.91 - $13.54 $2.32 Million - $2.88 Million
212,988 Added 3.06%
7,171,035 $79.5 Million
Q4 2022

Feb 21, 2023
BUY
$9.89 - $12.7 $794,028 - $1.02 Million
80,286 Added 1.17%
6,958,047 $85 Million
Q3 2022

Nov 14, 2022
BUY
$9.82 - $12.75 $1.09 Million - $1.41 Million
110,515 Added 1.63%
6,877,761 $71.8 Million
Q2 2022

Aug 15, 2022
BUY
$6.23 - $11.12 $1.4 Million - $2.49 Million
224,367 Added 3.43%
6,767,246 $72.7 Million
Q1 2022

May 16, 2022
BUY
$7.89 - $12.48 $1.96 Million - $3.1 Million
248,193 Added 3.94%
6,542,879 $62 Million
Q4 2021

Feb 11, 2022
SELL
$9.82 - $12.44 $706,038 - $894,411
-71,898 Reduced 1.13%
6,294,686 $72.7 Million
Q3 2021

Nov 12, 2021
BUY
$8.74 - $11.84 $679,473 - $920,477
77,743 Added 1.24%
6,366,584 $60.8 Million
Q2 2021

Aug 13, 2021
BUY
$8.71 - $10.72 $5.18 Million - $6.37 Million
594,646 Added 10.44%
6,288,841 $60.6 Million
Q1 2021

May 14, 2021
BUY
$9.2 - $23.86 $22.1 Million - $57.4 Million
2,407,160 Added 73.23%
5,694,195 $56.3 Million
Q4 2020

Feb 16, 2021
BUY
$13.47 - $24.89 $34.3 Million - $63.3 Million
2,543,281 Added 341.95%
3,287,035 $75.9 Million
Q3 2020

Nov 13, 2020
BUY
$12.89 - $15.89 $7.97 Million - $9.83 Million
618,632 Added 494.42%
743,754 $10.5 Million
Q2 2020

Aug 11, 2020
SELL
$8.86 - $15.69 $207,749 - $367,899
-23,448 Reduced 15.78%
125,122 $1.89 Million
Q1 2020

May 15, 2020
BUY
$6.63 - $11.16 $53,490 - $90,038
8,068 Added 5.74%
148,570 $1.37 Million
Q4 2019

Feb 14, 2020
BUY
$7.48 - $10.75 $1.05 Million - $1.51 Million
140,502 New
140,502 $1.37 Million

Others Institutions Holding FOLD

# of Institutions
278
Shares Held
324M
Call Options Held
260K
Put Options Held
261K
View Full List

About AMICUS THERAPEUTICS, INC.

FOLD Quotes by TradingView
  • Ticker FOLD
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 280,497,984
  • Market Cap $3B
  • Description
  • Amicus Therapeutics, Inc., a biotechnology company, focuses on discovering, developing, and delivering medicines for rare diseases. Its commercial product and product candidates include Galafold, an oral precision medicine for the treatment of adults with a confirmed diagnosis of Fabry disease and an amenable galactosidase alpha gene variant bas...
More about FOLD
Track This Portfolio

Track Macquarie Group LTD Portfolio

Follow Macquarie Group LTD and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Macquarie Group LTD, based on Form 13F filings with the SEC.

News

Stay updated on Macquarie Group LTD with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email